recombinant respiratory syncytial virus pre-fusion F protein vaccine


Depending on your search, some materials provided on this website may describe the use of Pfizer products outside of the Australian approved Product Information. Please review the Australian approved Product Information for important treatment considerations, including boxed and/or black triangle warnings (where applicable)
Product Information

Instructions for Use

Consumer Medicine InformationAustralian Immunisation Handbook

The use of Abrysvo should be in accordance with official recommendations. The Australian Technical Advisory Group on Immunisation have published recommendations for the use of respiratory syncytial virus vaccines in Australia, available here.
Please note that Pfizer is independent of these recommendations.

Additional Resources

Submit a medical question for a Pfizer medication or vaccine.

Your enquiry will be reviewed during our standard business hours.

Connect with Pfizer Medical Information regarding your medical question.

*9AM-5PM (AEST) Monday to Friday.

 

Medical Affairs Scientists are Pfizer subject matter experts on scientific information relating to Pfizer medicines and their uses.

To report an adverse event related to a Pfizer product, click the link below to submit your information:
Pfizer Safety Reporting Site

For concerns about the quality of a Pfizer product please call  1800 675 229.

If you cannot use the above website to report an adverse event related to a Pfizer product, please email us at AUS.AEReporting@pfizer.com.

You may also contact the Therapeutic Goods Administration (TGA) directly to report adverse events at www.tga.gov.au/safety/report-problem/report-adverse-event-or-safety-problem